FMC Corporation's fluindapyr fungicide obtains registration in Brazil

Rhea-AI Summary

FMC Corporation receives Brazilian registration for fluindapyr fungicide, expanding its market reach.

Positive

• Fluindapyr provides preventative control of a wide range of destructive diseases prevalent in Brazilian row crops.
• FMC expects to register several fluindapyr formulations in Brazil for use in cotton, corn, and soybean.
• The registration in Brazil marks another significant regulatory approval for FMC and fluindapyr.

Negative

• None.

PHILADELPHIA, Aug. 22, 2023 /PRNewswire/ --

FMC Corporation (NYSE: FMC), a leading agricultural sciences company, recently received Brazilian registration for fluindapyr, a novel broad-spectrum succinate dehydrogenase inhibitor (SDHI) fungicide. 

SDHI fungicides have become one of the most important tools for Brazilian growers. Fluindapyr provides preventative control of a wide range of destructive diseases prevalent in Brazilian row crops such as rusts, leaf spots and powdery mildew.

"FMC expects to register several fluindapyr formulations in Brazil for use in cotton, corn and soybean, including ONSUVA^® fungicide – a combination with difenoconazole," said Marcelo Magurno, FMC Brazil business director. "Our research demonstrates that fluindapyr is an effective fungicide and an excellent mixture partner to other fungicide active ingredients. It is compatible with best-in-class disease management programs providing Brazilian growers with preventative broad-spectrum control of various fungal diseases. Broad-spectrum disease control is critical since multiple diseases can attack the crop at the same time, leading to potential crop loss and a significant reduction in yield."

The registration in Brazil marks another significant regulatory approval for FMC and fluindapyr, which is already registered in Argentina, the United States, Paraguay and South Korea. The company has submitted fluindapyr formulations for registration in multiple other countries covering key markets in every region. Upon the grant of these registrations, growers around the world will have access to innovative disease management tools that complement their crop management programs and optimize their crop yield.

"FMC will bring to market high-performance fluindapyr premixture products that provide flexible and versatile resistance management with superior performance on key tough-to-control diseases," said Diane Allemang, FMC executive vice president and chief marketing officer. "FMC fluindapyr brands will provide growers across the globe the flexibility and versatility they need to customize their programs on multiple crops."

About FMC

FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. With approximately 6,600 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn^® and Twitter^®. 

ONSUVA is a trademark of FMC Corporation and/or an affiliate. Always read and follow label directions. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:  This release contains statements that are "forward-looking" and provide other than historical information.  FMC has identified forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "targets" "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases.  Such forward-looking statements, which are based on management's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These factors include, among other things, the risk factors and other cautionary statements included within FMC's 2022 Form 10-K filed with the SEC as well as other SEC filings and public communications. FMC cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. FMC undertakes no obligation, and specifically disclaims any duty, to update or revise any forward-looking statements to reflect events or circumstances arising after the date on which they were made, except as otherwise required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporations-fluindapyr-fungicide-obtains-registration-in-brazil-301906943.html

SOURCE FMC Corporation